Increase/Decrease in Cash: The total change in cash for the company over the given period.
VectivBio Holding AG (VECT) had Increase/Decrease in Cash of $118.71M for the most recently reported fiscal quarter, ending 2022-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$226.21M |
|
$0.46M |
|
$26.67M |
|
$252.60M |
|
$24.74M |
|
$10.32M |
|
$14.49M |
|
$39.23M |
|
$213.37M |
|
$187.22M |
|
$213.37M |
|
-- |
|
| Cash Flow Statement Financials | |
$-56.26M |
|
$-0.07M |
|
$175.06M |
|
$102.71M |
|
$221.42M |
|
|
Increase/Decrease in Cash |
$118.71M |
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|